449 related articles for article (PubMed ID: 25804887)
1. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
Oral Oncol; 2011 Apr; 47(4):274-7. PubMed ID: 21396880
[TBL] [Abstract][Full Text] [Related]
3. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
[TBL] [Abstract][Full Text] [Related]
4. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
Rashid A; Warnakulasuriya S
J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
[TBL] [Abstract][Full Text] [Related]
6. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
J Oral Pathol Med; 2011 Aug; 40(7):541-4. PubMed ID: 21615500
[TBL] [Abstract][Full Text] [Related]
7. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
[TBL] [Abstract][Full Text] [Related]
8. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
9. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
10. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
Swathi KV; Maragathavalli G; Uma Maheswari TN
Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
[TBL] [Abstract][Full Text] [Related]
11. Standard examination and adjunctive techniques for detection of oral premalignant and malignant lesions.
Kerr AR; Shah SS
J Calif Dent Assoc; 2013 May; 41(5):329-31, 334-42. PubMed ID: 23795518
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence visualization improves the detection of oral, potentially malignant, disorders in population screening.
Simonato LE; Tomo S; Scarparo Navarro R; Balbin Villaverde AGJ
Photodiagnosis Photodyn Ther; 2019 Sep; 27():74-78. PubMed ID: 31116999
[TBL] [Abstract][Full Text] [Related]
13. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
Ram S; Siar CH
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of the Optical Filter for Autofluorescence Glasses for Oral Cancer Curing Light Exposed (GOCCLES
Lajolo C; Tranfa M; Patini R; Fiorino A; Musarra T; Boniello R; Moro A
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564975
[TBL] [Abstract][Full Text] [Related]
15. Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring.
Paderni C; Compilato D; Carinci F; Nardi G; Rodolico V; Lo Muzio L; Spinelli G; Mazzotta M; Campisi G
Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):121-8. PubMed ID: 21781457
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of chemiluminescence in the diagnosis and screening of oral cancer and precancer: a systematic review and meta-analysis.
Kim DH; Lee J; Lee MH; Kim SW; Hwang SH
Braz J Otorhinolaryngol; 2022; 88(3):358-364. PubMed ID: 32847738
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.
Nagi R; Reddy-Kantharaj YB; Rakesh N; Janardhan-Reddy S; Sahu S
Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e447-55. PubMed ID: 26946209
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of autofluorescence imaging and histopathological investigation for oral potentially malignant disorders in Taiwan.
Chiang TE; Lin YC; Li YH; Wu CT; Kuo CS; Chen YW
Clin Oral Investig; 2019 May; 23(5):2395-2402. PubMed ID: 30302607
[TBL] [Abstract][Full Text] [Related]
19. Screening for oral cancer.
Jitender S; Sarika G; Varada HR; Omprakash Y; Mohsin K
J Exp Ther Oncol; 2016 Nov; 11(4):303-307. PubMed ID: 27849341
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope.
Ganga RS; Gundre D; Bansal S; Shirsat PM; Prasad P; Desai RS
Oral Oncol; 2017 Dec; 75():67-74. PubMed ID: 29224826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
